Tesla Stock: Regulatory Risks and Delivery Countdown Overshadow Energy Partnership; Wait for Robotaxi Proof

What happened

Tesla shares are in focus amid a mix of regulatory developments, looming Q2 delivery numbers, and a newly announced 16 GW energy partnership, but the core investment thesis remains unchanged. The DeepValue report underscores that the stock's valuation of ~$380 embeds a rapid autonomy monetization that is not yet visible, with robotaxi fleets still in the tens and wait times long. A NHTSA investigation into FSD safety violations (PE25012) adds regulatory overhang, and management's guided $25B+ capex for 2026 raises the risk of external funding if core EV cash flow softens. The energy partnership is a positive signal for storage growth, but Tesla itself noted tariffs hit energy harder than autos, limiting margin relief. Until the upcoming quarterly filing provides quantified robotaxi scaling KPIs or a clear catalyst in FSD monetization, the risk/reward remains unattractive.

Implication

The next 3-6 months are pivotal: Tesla must deliver observable progress in robotaxi fleet scale and utilization, or the bear scenario (negative FCF, NHTSA remedies) becomes more likely. The energy partnership does not address the core thesis gap. Maintain a WAIT stance with entry at $300 or below, and reduce exposure if capex guidance remains $25B+ without autonomy revenue.

Thesis delta

No material shift. The news reinforces the existing narrative: regulatory uncertainty and delivery pressures persist, while the energy partnership provides a modest tailwind but does not de-risk the autonomy timeline. The core thesis—that Tesla needs to prove robotaxi monetization at scale within 6 months—remains intact.